Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions

@article{Nelson2007ChemotherapyAC,
  title={Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions},
  author={Christian J. Nelson and Nina Nandy and Andrew J. Roth},
  journal={Palliative and Supportive Care},
  year={2007},
  volume={5},
  pages={273 - 280}
}
“Chemobrain” is the phenomenon of cognitive decline some patients may experience after chemotherapy. Current research indicates the cognitive domains that may be most impacted by chemotherapeutic agents are visual and verbal memory, attention, and psychomotor functioning. These cognitive deficits can have an effect on a patient's ability to make informed treatment decisions, pursue occupational or academic pursuits, and his or her overall quality of life. The potential mechanisms that cause… 
Chemobrain: Can we consider an acquired brain injury from chemotherapy?
TLDR
There are significant differences between patients and control group before starting treatment, symptoms of anxiety, depression, quality of life and sleep, sexual function and neurocognitive variables in me- mory and executive function.
Emerging pharmacotherapy for cancer patients with cognitive dysfunction
TLDR
A number of emerging pharmacotherapies are under investigation for the treatment of cognitive dysfunction experienced by cancer patients, involving the stimulants modafinil and methylphenidate, mood stabiliser lithium, anti-Alzheimer’s drugs memantine and donepezil, as well as other agents which are currently being explored within dementia, animal, and cell culture models.
Cognitive Effects of Cancer Treatment: "Chemo Brain" Explained
TLDR
Proposed pathophysiology, signs and symptoms, and potential contributing factors of chemotherapy-induced cognitive impairment are described and potential treatment strategies, including pharmacologic and nonpharmacologic interventions, also will be discussed.
Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity
TLDR
Results indicate that chemobrain is associated with cytokine dysregulation and disrupted neuroplasticity of the brain.
Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?
  • S. Acevedo
  • Biology, Medicine
    Breast cancer : basic and clinical research
  • 2012
TLDR
There is an overwhelming need in the field to understand whether the water maze is an adequate model for post-chemotherapy impairments or whether other paradigms should be used.
An overview of chemotherapy-related cognitive dysfunction, or 'chemobrain'.
  • H. Moore
  • Psychology, Medicine
    Oncology
  • 2014
TLDR
Evidence that chemotherapy contributes to both subjective and objective changes in cognition is increasing, with effects appear to be most pronounced in the short-term, with improvement over time expected for most patients.
Cognitive impairment and chemotherapy: a brief overview.
Changes of Cognitive Function and Fatigue following Chemotherapy in Patients with Gastrointestinal Cancer: A Prospective Controlled Study
  • P. Oh, S. Moon
  • Medicine, Psychology
    Asian Oncology Nursing
  • 2019
TLDR
Further research is required to determine Changes of Cognitive Function and Fatigue following Chemotherapy in Patients with Gastrointestinal Cancer: A Prospective Controlled Study.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible.
TLDR
A number of potential, novel interventions that could be tested in clinical trials as treatments for chemotherapy-induced cognitive dysfunction in women with breast cancer are considered.
Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.
TLDR
Improved patient function in the setting of a progressive neurologic illness is demonstrated and methylphenidate should be more widely considered as adjuvant brain tumor therapy.
The effects of hormone therapy on cognition in breast cancer
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
TLDR
It is suggested that cognitive impairment may follow conventional adjuvant chemotherapy treatment and warrant replication with a controlled and more rigorous longitudinal design.
What is the effect of systemic anticancer treatment on cognitive function?
Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer
TLDR
The literature relevant to the cognitive impact of standard-dose chemotherapy in adults is reviewed, methodological issues related to the study of cognitive functioning in people with cancer are outlined, and future directions for research in this area are discussed.
Chemotherapy-related cognitive dysfunction in breast cancer.
TLDR
Chemotherapy-related cognitive dysfunction in patients with breast cancer is multifactorial and possibly related to anemia or a direct effect of chemotherapy on brain function.
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.
TLDR
High-dose chemotherapy appears to impair cognitive functioning more than standard- dose chemotherapy, and central nervous system toxicity may be a dose-limiting factor in high-dose cancer treatment regimens.
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects.
  • A. Scherwath, A. Mehnert, U. Koch
  • Medicine, Psychology
    Annals of oncology : official journal of the European Society for Medical Oncology
  • 2006
TLDR
Five years after treatment, standard- dose patients were slightly, but not significantly, more impaired in cognitive performance than high-dose patients, and no significant between-group differences on the late neuropsychological outcome were found.
Achieving and maintaining cognitive vitality with aging.
TLDR
The data presented in this review should interest physicians who provide preventive care management to middle-aged and older individuals who seek to maintain cognitive vitality with aging.
...
1
2
3
4
5
...